Vigil Neuroscience Inc (VIGL) concluded trading on Thursday at a closing price of $2.35, with 42.15 million shares of worth about $99.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.10% during that period and on January 23, 2025 the price saw a gain of about 15.76%. Currently the company’s common shares owned by public are about 39.67M shares, out of which, 19.36M shares are available for trading.
Stock saw a price change of 22.40% in past 5 days and over the past one month there was a price change of 41.57%. Year-to-date (YTD), VIGL shares are showing a performance of 38.24% which decreased to -22.70% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.49 but also hit the highest price of $6.06 during that period. The average intraday trading volume for Vigil Neuroscience Inc shares is 230.18K. The stock is currently trading 29.01% above its 20-day simple moving average (SMA20), while that difference is up 3.84% for SMA50 and it goes to -27.90% lower than SMA200.
Vigil Neuroscience Inc (NASDAQ: VIGL) currently have 39.67M outstanding shares and institutions hold larger chunk of about 35.91% of that.
The stock has a current market capitalization of $96.07M and its 3Y-monthly beta is at 1.82. It has posted earnings per share of -$2.07 in the same period. It has Quick Ratio of 3.72 while making debt-to-equity ratio of 0.15. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VIGL, volatility over the week remained 14.85% while standing at 11.53% over the month.
Analysts are in expectations that Vigil Neuroscience Inc (VIGL) stock would likely to be making an EPS of -0.47 in the current quarter, while forecast for next quarter EPS is -0.52 and it is -2.06 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.5 which is -0.44 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.57 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.38% while it is estimated to increase by 8.76% in next year.
Coverage by Morgan Stanley stated Vigil Neuroscience Inc (VIGL) stock as an Underweight in their note to investors on December 19, 2023, suggesting a price target of $4 for the stock. On October 18, 2023, JMP Securities Initiated their recommendations, while on March 31, 2023, Mizuho Initiated their ratings for the stock with a price target of $15. Stock get an Outperform rating from Wedbush on September 16, 2022.
